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Abstract— Advances in sensing technology raise the possibility
of creating neural interfaces that can more effectively restore
or repair neural function and reveal fundamental properties of
neural information processing. To realize the potential of these
bioelectronic devices, it is necessary to understand the capabilities
of emerging technologies and identify the best strategies to
translate these technologies into products and therapies that
will improve the lives of patients with neurological and other
disorders. Here, we discuss emerging technologies for sensing
brain activity, anticipated challenges for translation, and perspec-
tives for how to best transition these technologies from academic
research labs to useful products for neuroscience researchers and
human patients.
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I. INTRODUCTION
NEW sensing technologies capable of recording fromlarge numbers of neurons for extended periods of time
could fundamentally improve our understanding of the brain
and the treatment of neurological disorders. Recent advances
in sensing technologies from a variety of research domains
promise to provide just such improvements in neural interface
technology, but each of these approaches have unique techno-
logical challenges and opportunities.
As part of the IEEE Brain Initiative, we recently gathered a
group of researchers and stakeholders in Glasgow, Scotland to
discuss the current state of the art for some of these emerging
sensing technologies and the opportunities and challenges they
present. This review focuses on emerging brain sensing tech-
nologies that currently reside in the academic research domain
and may come to market in the coming years. For readers
interested in brain sensing technologies that are currently
commercially available, we encourage them to explore one
of the excellent recent reviews of commercial brain sensing
technologies [1]–[3].
In preparing this review we identified three areas where
advanced sensors could disrupt brain sensing technology:
1) New electrode technologies (Section III), 2) Integrated
optical sensors (Section IV), and 3) Magnetic field sensors
(Section V). In Section VI we summarize the panel discussion
regarding the opportunities and challenges for emerging sens-
ing technologies. Before exploring each of these technologies
in detail, we first describe the sensing challenge facing brain
interfaces and potential opportunities for these sensing modali-
ties. After describing recent efforts in these areas, we conclude
with a summary of a panel discussion that occurred during the
Glasgow meeting where we discussed grand challenges for the
brain sensing community.
II. CHALLENGES FOR BRAIN SENSING AND
OPPORTUNITIES FOR NEW TECHNIQUES
At a fundamental level, sensors that detect the spiking
activity of individual neurons convert sub-millivolt voltages
within the brain into electronic signals in the solid-state
circuits where all data processing occurs [4] (Fig. 1). This
conversion is typically performed using an electrical inter-
face between the electrolyte solution in the brain and a
metal or organic electrode and associated electronics [5].
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Fig. 1. Sensing modalities for measuring neural activity discussed in this
review. (Left) Neural action potentials can measured based on changes in
electrical potential near the cell body, Section III. (Center) Action potentials
can also be detected with light based on changes in fluorescence or changes in
transmission of electro-optic waveguides, Section IV. (Right) Neural activity
can also be detected based on the magnetic fields produced by currents
propagating along neural processes, Section V.
Alternatively, light can act as an intermediary where electrical
activity is encoded into the intensity of light that is scattered,
absorbed [6], for emitted through fluorescence [7], [8] or
bioluminescence [9], [10]. It may even be possible to sense
this electrical activity by modulating light that passes through
a waveguide with electro-optic elements [11]. The currents
produced during spiking activity also produce magnetic fields
that can be detected non-invasively outside the brain [12].
Each of these sensing modalities have unique opportunities
and challenges that we address in turn in the sections below.
III. ELECTRICAL SENSING OF BRAIN ACTIVITY
Electrodes have the advantage of direct transduction of the
voltage produced by neurons, but require close proximity to
the cells they intend to study, placing a premium of tech-
nologies that minimize damage to the brain. In neuroscience,
these electrodes can record voltages in the surrounding elec-
trolyte; stimulate voltages in surrounding electrolyte; patch
neurons [13], measuring voltages and currents; or perform
electrochemical analysis of redox-active compounds, such as
neurotransmitters [14]–[18]. Each of these applications puts
different requirements on the electrodes (and the interfacing
electronics). In other words, electrodes need to be designed
together with the electronics to which they are connected.
Direct electrical transduction brings many advantages, but
in contrast to the remote sensing possible with optical tech-
niques, electrodes must be within roughly 100-200 microns
of an electrically active cell to isolate action potentials. This
requirement for close proximity raises challenges in creating
electrodes with appropriate form factors. Biological systems
are curved and malleable, while solid-state devices are hard
and flat, a difference that can be handled in one of two ways.
One can miniaturize the device with respect to the biological
tissue (e.g. ultra-small solid-state devices), or one can cre-
ate solid-state devices that can conform to biological tissue
(e.g. flexible or pliable electronics) [19].
A. CMOS Bioelectronics for Brain Sensing
When choosing to employ electronic interfaces, there are
enormous advantages to integrating these interfaces with state-
of-the-art complementary metal-oxide-semiconductor (CMOS)
electronics. First, integration of electronics close to the elec-
trodes improves signal fidelity by delivering gain closer to the
transducer, improving noise performance. CMOS-integrated
electronics also enable dense electronics, having the potential
to mirror the kind of densities achieved in CMOS imagers.
Time-multiplexing of amplifiers is another technique used to
optimally exploit the density of electronics available [20].
Electrodes themselves fall into two main categories:
Faradaic and non-Faradaic [21]. Non-Faradaic electrodes are
sometimes also called ideal polarized electrodes (IPE); they
present a capacitive interface with no dc current conduction.
Electrophysiology electrodes are essentially non-Faradaic.
Faradaic electrodes, in contrast, allow dc current flow and
are needed if electrochemical analysis is performed. For
non-Faradaic electrodes, electrode impedance is usually mea-
sured at 1 kHz and it is essentially the magnitude of the
capacitive impedance of the electrode, or |1/wC|. Optimizing
non-Faradaic electrodes typically is synonymous with increas-
ing the capacitance of the electrode, which is usually done by
increasing the effective capacitance per unit area. Increase in
capacitance is usually accomplished by increasing the surface
area through a “porous” surface, such as platinum black and
TiN. Another approach is the addition of organic conduct-
ing polymers such as PEDOT:PSS [22] as described below.
Scaling the electrodes to smaller capacitance values increases
the noise on the electrode according to kT/C, although more
practical limitations on scaling the capacitance on the electrode
may come from the interfacing electronics and the associated
capacitance divider, which reduces signal.
Active CMOS multielectrode arrays, employed primarily for
in vitro neural studies such as of the retina, set the standard for
the density and scaling of the electronics for electrophysiology.
Recent work has produced arrays supporting as many as
65k simultaneous recording and stimulating channels [23].
To expand these efforts to in vivo measurement, one of four
form factors is required:
• Penetrating Shanks (flexible and rigid). Both passive
[24] and active [25] versions penetrate the cortex and
transmit data wireless or via wires to the surface. Form
factors include single or multi-electrode and some flexible
versions can be injected through syringes or using fluidic
microdrives as described below.
• Surface recording arrays. These are both passive [26]
and active [19] and are capable of recording both local
field potentials (LFPs) and single-unit responses (action
potentials). These can be both wired and wireless.
• Ultra-small free-floating motes. These must generally
communicate wirelessly to the surface of the brain
or skull.
There have been several efforts associated with the develop-
ment of passive silicon shanks. By “passive,” we mean that the
shanks themselves have no active electronics. With advanced
packaging approaches and custom application-specific
integrated circuits (ASICs) for the electronics, passive silicon
shanks have been scaled to 1024 electrodes on a single
shank. Active CMOS shanks integrate the electronics on
the shank itself and can achieve similar scales. Ultra-small
passive wired electrodes can be injected [27] or developed
into large bundles [28]. There are also passive and active
surface recording electrodes using flexible polymer materials
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Fig. 2. Example of thin, flexible CMOS electronics. When thinned below
15 µm in thickness silicon electronics can bend and flex to match complex
topographies like those in the brain to provide close contact with neural tissue.
Here we see a flexible array of neural electrodes wrapped
as substrates. Active CMOS arrays can also be created
by thinning silicon CMOS down to thicknesses below
15 mm, rendering these devices flexible and pliable [29].
Ultra-small wireless implants generally require other energy
modes for communication and telemetry at depth, including
ultrasound [30]–[32], or magnetic fields [33].
Electrical interfaces continue to be an important type of
neural interface and maintain several advantages over optical
approaches, however they are generally more invasive and
require close proximity with the target neurons. The optimal
choice of electrode type depends on the problem at hand, and
it is often critical to codesign the electrodes and the associated
electronics. Scaled CMOS electronics is an important part of
the story, and CMOS can be shaped into unusual form factors.
Flexibility and small sizes are keys to building these interfaces.
Important research topics in electrode development include
organic electronics that can increase the capacitance of the
electrode-electrolyte interface, nanoscale form factors that
can reduce a foreign body response from the tissue, and
minimally invasive delivery strategies that can improve chronic
electrode performance. These research areas are described in
the following sections.
B. Organic Bioelectronics for Brain Sensing
Organic synthesis allows one to create bioelectronic mate-
rials with tunable properties, compatibility with flexible sub-
strates, and mixed electronic/ionic conduction [34], [35], all of
which have advantages for brain sensing and can be combined
with CMOS bioelectronics. This mixed electronic/ionic con-
ductivity, in particular, enables one to lower the impedance
of neural electrodes. For example, a thin (∼100 nm) coat-
ing of a commercially available conducting polymer such
as PEDOT:PSS, can lower the impedance of a Au elec-
trode by a factor of 100 [36]. When such electrodes are
integrated with thin plastic films, they allow the fabrication
of ultra-conformable cortical grids that provide exceptional
spatial resolution. One example is the NeuroGrid, a parylene-
based conducting polymer microelectrode array that allows
single neuron recordings without penetrating the cortex [37].
The same property of mixed conductivity allows the fab-
rication of electrochemical transistors. In these devices, ions
from the cerebrospinal fluid enter the polymer channel and
change the electrical conductivity throughout its volume [38].
This mechanism of operation is associated with a very large
transconductance and these transistors act as amplifying trans-
ducers, recording neural activity with higher signal-to-noise
ratio than electrodes of the same size [39].
Moreover, electrochemical transistors can be functionalized
with redox enzymes, acting as sensitive sensors for metabolites
such as glucose and lactate. Recent work shows that these
devices offer good stability in cell culture media and that
they can measure changes in metabolic activity with a high
sensitivity [40]. These devices are now en route to implantable
applications, with the aim of combined measurements of
electrophysiology and metabolism in the same location of the
brain. In the form of organic light-emitting diodes (OLEDs),
organic electronics can be a useful way for local generation
of light as will be described in Section IV, B.
C. Nanoelectronics for Improving Long-Term
Neural Interfaces
As described above, electrodes are one of the most impor-
tant effective methods for time-resolved electrical detection
of individual neuron activities in the living brain [41]–[47].
However, reliable tracking of the same groups of neurons
over days to months and years with neural electrodes has
been challenging, mainly due to their unstable performance
over long-term implantation [48]–[50]. The stresses in the
implants induced by the motion of the surrounding tissue
often leads to structural damages of the neural electrodes
and abrupt loss of recording capacity [51]–[54]. Moreover,
these implanted electrodes also induce substantial damage to
the host tissue [55]. This damage is often attributed to the
large dimensions, surgical footprints, and mechanical rigidity
of stiff neural electrodes. In the short term, the mechani-
cal mismatch between tissue and implants induces electrode
movements with respect to target neurons [56], which leads
to sudden waveform changes on time scales as short as
hours, preventing reliable tracking of individual neurons over
days and longer [57], [58]. In the long term, the presence
of implants causes recurring cellular and vascular damage,
elicits sustained inflammation and tissue response [59] that
results in neuronal degeneration and glial scar formation near
the implants [55], [60], [61]. These chronic deteriorations are
manifested in electrical recordings as loss in recording yield,
amplitude and fidelity [61]–[64], greatly limiting their appli-
cation in both fundamental and clinical neuroscience.
There has been a growing awareness that reducing the
neural probe’s dimension [66] and rigidity [61], [67], [68]
can improve the tissue-probe interface, raising the prospect
of improved chronic performance for tiny flexible elec-
trodes. Recent demonstrations of ultra-flexible nanoelectronic
threads (NETs) [65] and flexible electrode meshes [69] indeed
show improved stability of neural recording. For example,
NET electrodes can reliably detect and track individual neu-
rons for over three months; and the electrode impedance, noise
level, single unit yield, and the signal amplitude remained
stable over long-term implantation. In vivo two-photon
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Fig. 3. Penetrating polymer-based ultra-flexible electrodes can match the
mechanical properties of the brain by virtue of their thin substrates. These
types of ultra-flexible probes can minimize the body’s foreign body response
and support stable long-term electrical interfaces. (scale bars 10 µm). [65]
imaging and postmortem histological analysis show fully
recovered capillaries with an intact blood-brain barrier,
absence of chronic neuronal degeneration and glial scar. Future
work is underway to scale up these ultra-flexible electrodes to
achieve large-scale, high-density and long-term neural record-
ing [70], and combining electrical measurements with optical
imaging [71], [72].
D. Realizing the Promise of Flexible Electrodes via
Microfluidic Insertion
While very small and/or very flexible electrodes are likely
to improve chronic recording performance [73], [74], devices
that are small and/or flexible are typically quite fragile, and
thus difficult to insert into the brain. As a result, most solutions
which accommodate scales of 100s or 1000s of electrode sites
currently use some form of transient stiffening to insert devices
into the brain. The two most common forms of transient
stiffening are dissolvable coatings and the attachment of a
stiffener with a dissolvable adhesive or temporary mechanical
connection [75]–[77]. The problem with these solutions is
that the stiffened devices still cause trauma during insertion,
in particular, damaging the microvasculature of the brain in
the areas in which they are inserted [78], [79].
In order to minimize insertion trauma, researchers have
developed a novel technique to insert flexible probes into
the brain without stiffening [80]. For any probe, the primary
mechanism of insertion failure is buckling in regions that are
unsupported, i.e., between the brain surface and the location at
which force is applied [81], [82]. Using microfluidic channels
to support the electrode along the entire length it is possible
to increase the amount of force the probe can tolerate before
buckling as it is inserted. Within the microfluidic channel,
drag from high speed fluid flow drives the electrode into
the brain. Large return ports proximal to the end of the
channel capture 98.5% of the fluid to ensure that the drive
fluid does not penetrate or damage the brain. Thus, while
this approach shares some similarity with a recently-reported
syringe injection-based approach [27], [83], neither the drive
channel nor the fluid are able to damage the brain during elec-
trode insertion. Using this fluidic microdrive, researchers have
successfully inserted single channel flexible carbon nanotube
Fig. 4. Ultraflexbile carbon nanotube fiber (CNTf) probes buckle when
pressed into an agar brain phantom (left). A fluidic microdrive that supports
the bare fiber during actuation facilitates implantation without increasing the
footprint of the electrode (right) [80]. Scale bar 2 mm.
fiber electrodes into model organisms (the cnidarian Hydra
vulgaris), acute mouse brain sections, and the in vivo rat brain.
With this approach it is also possible to control the depth of the
probe by actuating the drive fluid pressure [80]. Subsequent
work has also demonstrated that using a dissolvable polymer
support can also stabilize a flexible implant near the insertion
point to help prevent buckling [82] (Fig. 4). By removing the
need for a stiffener, it may be possible to simplify the process
of electrode insertion by removing the need for dissolution of
an adhesive as well as significantly reducing the damage done
to the brain during implantation. Improved methods like these
for implanting small and highly flexible electrodes will be
instrumental in facilitating the next generation of high-channel
count chronic neural electrode arrays.
E. Stability and Functionality of Flexible Electrodes
In addition to improving system integration and perfor-
mance of the electrodes at tissue interface, long-term studies
in fundamental neuroscience as well as clinical applications
in humans also require that these interfaces are robust and
reliable with life times from years to decades. While there is
plenty of knowledge in the medical devices field with cardiac
pacemakers, cochlear implants and deep brain stimulators,
the underlying technologies using precision mechanics limit
the degree of miniaturization and the number of electrodes and
cannot be directly transferred into miniaturized neural implants
with dozens to hundreds of channels [84].
As described above, CMOS and other micro (opto-) electro-
mechanical systems (M(O)EMS) offer adequate levels of
miniaturization but still have to prove long-term stability in
chronic preclinical and clinical settings [84]. Package, sub-
strate and electrode materials have to be stable in the body,
must not be toxic and as described above should minimize the
mechanical mismatch between the neuronal target tissue and
the implant to limit foreign body reaction due to structural
biocompatibility issues.
One approach for neural interfaces applying MEMS tech-
nologies uses polyimide as flexible substrate and insulation
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material and thin-film metallization for electrodes, intercon-
nect lines and contact pads to cables and implant packages.
Adhesion between the different materials and layers has been
identified as one of the key properties for long-term sta-
bility [84]. Reliable assembling to either telemetric systems
or wired connectors is mandatory for recording of nerve
signals or electrical stimulation. Devices have been designed
according to the anatomical and neurophysiological targets
in the central and peripheral nervous system. Customized
electrode arrays for chronic recording of electrocorticograms
have been developed [85] for ferrets [86] and non-human
primates [87] with wired connectors. Modular device designs
go currently up to 1024 channels without the need of mul-
tiplexing electronics. However, the percutaneous headposts
limit transition into clinical settings, at least in Europe. Fully
implantable, wireless systems [88] overcome this limitation
but have to time-multiplex the transmission of data. Signal
processing and data compression or algorithms on the implant
reduce the amount of data to be transferred. In the peripheral
nervous system, mechanical forces on the implant due to
muscle contractions have to be considered in system design.
Functional interfaces have been miniaturized and combined
with robust cables in the TIME concept [89] for interfacing
arm nerves after amputation to deliver sensory feedback in
hand prosthesis control in subchronic conditions [90] and up
to six months [91]. The lack of high-channel count implantable
connectors currently limits the usability and translation of
these approaches into medical devices for clinical use world-
wide. Optoelectronic probes for optogenetic applications face
similar challenges [92]. Thermal management of implanted
light sources, their hermetic packaging and the transparency
of waveguides are current bottlenecks [93] for long-term
application.
Foreign body reaction leads to scarring reaction around the
implants deteriorating the transfer properties of the electrical
and optical channels. Carbon as electrode material delivered
promising results with respect to reduced tissue reaction [94].
Incorporation of drugs in conductive polymers and delivery on
demand [95] is another option to actively control reactions at
the material-tissue interface for long-term functional interfaces
to the nervous system and reliable performance of neural
implants.
Thus, in addition to carefully developing sensors at the
biotic-abiotic interface, it is critical to design systems for data
and power transfer that support these sensors over long periods
of time in the harsh and delicate environment inside the body.
IV. OPTICAL BRAIN COMPUTER INTERFACES
Using light to sense neural activity has several advantages
compared to electrical interfaces. Photons in brain tissue
typically travel between 50 and 100 microns before scattering,
allowing one to image individual cortical neurons from the sur-
face of the brain. This imaging ability combined with advances
in designer proteins for stimulation and measurement, allows
one to interface with select cell types [96]–[98]. This cell-
type-specific information combined with less invasive interro-
gation, and the ability to image many cells at once is raising
interest in optical brain interfaces.
Light, however, is not without disadvantages. Information
transferred through photons is limited by shot noise, which is
most pronounced at high bandwidths and at the low signal
levels characteristic of optical reporters of neural activity.
The use of light is also an indirect measure of biophysical
processes since, in nearly all cases, biological systems must be
engineered to emit or be sensitive to light. Photobleaching also
limits measurement time. Instrumentation is complex – micro-
scopes are big and bulky generally, despite recent advances in
lensless and filterless imaging systems. To overcome some of
these challenges, researchers are investigating ways to make
miniature, lensless microscopes with dramatically reduced size
and weight, and looking toward electrooptic effects that would
eliminate the challenges associated with photobleaching.
A. Flat Lensless Microscopes for Implantable
Optical Interfaces
Chief among the challenges facing an optical brain com-
puter interface is the creation of a fully implantable imaging
system that covers significant areas of the cortex. While minia-
ture microscopes have shown promise for imaging activity in
freely moving animals [99], [100], these microscopes rely on
traditional architectures that use lenses to magnify the image.
As a result, the imaging system must be much larger than the
field of view, making it difficult to image large areas while
maintaining the small form factor necessary for an implanted
device [99]. Thus, small microscopes traditionally have small
fields of view.
One approach to overcome the limitations inherent to lens-
based microscopes is to replace lenses with compact phase
or amplitude masks and computational imaging algorithms to
recover an accurate estimate of the scene based on complex
sensor data (that may not initially look like an image). One
approach called “FlatScope” is a device less than a millimeter
thick that maintains micron-scale resolution over a field of
view several millimeters across (Fig. 5). In addition to the
compact form factor, computational imaging employed by
FlatScope allows one to refocus images to different depths,
which enables 3D volumes to be reconstructed from a sin-
gle image capture. Thus, high-frame-rate 3D images can be
reconstructed to potentially reveal neural activity across neural
circuits [101].
While flat, lensless microscopes may solve the size and
weight challenge for optical interfaces, there remains a need
for brighter and more stable fluorescent indicators of neural
activity, as well as more sensitive image sensors that can
be incorporated into devices like the FlatScope. Promising
new single-photon-sensitive sensors may provide just such
advances in imaging technologies. Secondly, to image beyond
the first few hundred microns of cortex requires technologies
to mitigate the effects of light scattering by brain tissue.
While multi-photon microscopy is the most common method
to increase the optical imaging depth, it is unclear if the
required pulsed lasers can be integrated into chip-scale neural
interfaces. One alternative could be to produce light within
the brain via bioluminescence to overcome the effects of
excitation scattering and enable deeper imaging. Alternatively,
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Fig. 5. FlatScopes like the one shown on the tip of a figure have no lenses
making them ultrathin and lightweight. However, without lenses, the captured
images do not resemble the ground truth (shown here in a confocal micro-
scope image of fluorescent microspheres). Nevertheless, by using specially
designed diffractive or amplitude masks placed directly on the sensor, one
can computationally reconstruct an image that closely matches the ground
truth [101], [102].
integrated photonic probes that produce sheets of excitation
light could more than double the imaging depth achieved by
epifluorescence microscopy [103].
B. Organic LEDs for Brain Optical
Stimulation and Imaging
While advances in CMOS technology allow production of
fast and sensitive megapixel image sensors, generation of light
by miniature integrated electronics remains a challenge, limit-
ing its use for all optical neuronal interfacing, which requires
photostimulation of neurons, e.g. through optogenetics, and
in many cases excitation of fluorescent voltage or calcium
reporters. This is a fundamental limitation of silicon due to
its indirect bandgap. One avenue to circumvent this issue
is to bond conventional micro LEDs, e.g. based on GaN,
onto the silicon chip [104]–[106]. However, due to the lattice
mismatch of GaN and Si, this integration requires involved
post-processing, e.g. through flip-chip bonding, which to our
knowledge has so far prevented development of megapixel
active matrix CMOS LED arrays for optical neuronal record-
ing or optogenetic stimulation.
In recent years, researchers have begun to use monolithic
integration of organic-semiconductor based LEDs (OLEDs)
on CMOS chips. Due to their amorphous nature,
organic-semiconductors can be deposited on a wide variety
of substrates using conventional vacuum techniques like
physical vapor deposition or even solution-based approaches.
This characteristic of the OLED technology is the principal
reason for its great success in the display industry, from small
smartphone displays to large TVs. Further benefits of OLED
technology in the context of brain-computer interfaces are
their intrinsic mechanical flexibility that allows integration on
flexible and thus potentially less invasive devices, the ease of
color-tuning across the entire visible range of the spectrum,
and the fact that their physical dimensions are readily scalable
from many cm2 down to the µm2 range. By modifying OLED
microdisplays that were originally developed for near-to-eye
display applications, we demonstrated photostimulation of
channelrhodopsin 2 (ChR2) expressing cells from >105 indi-
vidually addressable blue-emitting OLED pixels [107], [108].
A potential weakness of OLEDs is their sensitivity to
water and oxygen, and so we have optimized thin-film
encapsulation and passivation methods based on atomic layer
deposition to enable prolonged operation of OLEDs in a tissue
environment [109]. Using the concept of molecular doping,
we have also realized OLEDs that achieve brightness levels
100-1000 fold higher than conventional displays and have
demonstrated that these allow robust photo-stimulation of
individual neurons and small animals genetically transduced
to express the latest generation channelrhodospins as well as
genetically encoded calcium indicators [110], [111].
C. Electro-Optics for Ultraminiature Brain Sensors
Light may also provide an answer for ultraminiature multi-
channel brain sensors. While the multi-site electrical neural
probes describe above have enabled multiplexed neural activity
measurements [25], their level of miniaturization is con-
strained by several factors. First, in current implementations,
each recording site uses a dedicated electrical trace (i.e.,
a wire, often lithographically integrated into a substrate) to
convey its signal to the outside world or to a relay station
where amplification and/or digitization may occur. After the
digitization stage, many neural signals may be transmitted
along a single electrical wire, but prior to this stage, multi-
plexing requires one wire per recording site. As wires become
thinner, we run into limits of fabrication as well as of
increasing electrical Johnson noise with increasing electrical
resistance [11]. Moreover, if we wish to record at high density
at many sites along a long shank, e.g., centimeters in length,
the number of wires which must be packed into a single probe
increases, or alternatively, power-consumptive amplification
and digitization stages must be placed closer to the measured
neurons, increasing the complexity of heat dissipation and
introducing additional safety considerations.
One potential solution to these problems is to multiplex
neural signals optically, into an optical fiber. Because vis-
ible or infrared light contains terahertz (THz) frequencies,
the available signal bandwidth in an optical context is very
high, concordant with the use of optical communications for
long-range data transfer in the telecommunications industry
and increasingly in parallel computing hardware. Optical
communication channels, in addition, can potentially shrink
towards the size of the optical wavelength, e.g., in the range
of one micron, or below using plasmonic or other optical
confinement techniques. Because the light is confined to an
optical fiber in such a scenario, the massive optical scattering
of the brain tissue does not pose a problem.
To implement such optical multiplexing, there are two
possibilities. One is to amplify and/or digitize locally and
then transmit via optical fiber. This has some of the same
issues, however, in terms of size and power consumption as
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a pure electrical approach. An alternative possibility is to
leverage electro-optic modulation to allow an un-amplified
neural signal to be directly transduced into a detectable
modulation of an optical wave traveling in a small optical
fiber. Electro-optic modulator devices which can create such
effects are, interestingly, now scaled down to the micrometer
size scale [112], and moreover, although they typically use
1V-scale electrical voltages and switch in the gigahertz (GHz)
range, both the speed (kHz) and size of signal (100 microvolt),
are proportionately reduced in a neural sensing application.
In addition, time-domain or frequency-domain reflectometry
techniques can now reach ∼10 micrometer spatial resolution
within optical fibers [113], and low-coherence reflectometry
in optical fibers can achieve similar high resolution and high
speed performance as free-space optical coherence tomogra-
phy which is often applied on the micron scale as well [114].
Recently, preliminary designs have been proposed to allow
fiber-based electro-optic neural activity sensing [115]. The
design is similar to that of free carrier effect based electro-
optic modulators. Based on an analysis of photon shot noise
in the system, the authors concluded that neural sensing
was possible, if a sufficiently high capacitance can be fab-
ricated inside the proposed engineered waveguide. Improved
designs using resonant enhancement of the electro-optic effects
via optical cavities, or improved capacitor materials, could
allow the still-hypothetical system to operate at lower light
powers, reducing heat dissipation from the fiber. With such
improvements, as well as improvements in the reflectometry
or multiplexing scheme, e.g., wavelength multiplexing, it may
be possible to engineer ultra-long (e.g., centimeters), ultra-
multiplexed, low-power neural activity sensors for deployment
into the brain tissue or via the cerebral vasculature [115].
Achieving this will require creative designs from nano-
photonics experts via a cross-disciplinary collaboration with
neurophysiologists, materials scientists and experts on optical
detection methods.
V. MAGNETOENCEPHALOGRAPHY WITH
ATOMIC MAGNETOMETERS
Compared of electrical and optical techniques, magnetic
sensing of neural activity has the advantage of being com-
pletely non-invasive and has high temporal resolution. How-
ever, the fields produced are so small compared to the earth’s
magnetic field. As a result, the measurement of such fields
has been traditionally carried out by magnetometers based on
superconducting quantum interference devices [116], which
achieve the required sensitivities, but which require cryogenic
cooling and are large, expensive and cumbersome to operate.
Recent improvements in the sensitivity of atomic
magnetometers [117], which are based on the precession of
the spins of alkali atoms in the vapor phase, now allow these
sensors to be used for magnetoencephalography [118] and
there is growing interest within the biomagnetics community
in these sensors [119]. The key advance that led to the
improved sensitivity is the reduction of spin-exchange
relaxation [120], which can severely limit the sensitivity at
high alkali densities. Magnetometer sensitivities at or below
Fig. 6. Magnetoencephalography for capturing brain activity. A) Liquid-
helium cooled magnetometers for traditional MEG are large and heavy
instruments. B) Optical magnetometers, on the other hand, operate at room
temperature and can be miniaturized. C) Using miniature optical magnetome-
ters it is possible to create small form factor MEGs that operate at room
temperature. Reproduced from [125] with permission.
1 fT/
√
Hz have been demonstrated in the laboratory and
commercial magnetometers with a sensitivity of 15 fT/
√
Hz
are available commercially [121].
Along with the improvements in sensitivity obtained over
the last decade, there have been parallel improvements
in miniaturization and manufacturability. Chip-scale atomic
magnetometers [122], [123] combine the high precision of
alkali magnetometers with the small size afforded by sili-
con micromachining processes. By confining the atoms in a
millimeter-scale micromachined vessel and probing the atomic
spins using light from a low-power laser, substantial reductions
in power consumption, volume and cost can be obtained. For
magnetoencephalography, the main advantages of chip-scale
technology are that high spatial resolution can be obtained,
and the sensors can be placed closer to the skull, resulting
in improved signal strength. Spontaneous brain activity and
evoked responses have been measured [124] in human subjects
with chip-scale atomic magnetometers, and epileptic spiking
has been measured in rats [121].
It is anticipated that further development of this
sensor technology may lead both to portable systems
capable of, for example, measuring brain activity during
epileptic seizures, and to operation without the stringent
shielding requirements required for superconducting quantum
interference device (SQUID)-based systems (Fig. 6) [125].
These, along with further commercial development of the
sensor technology and integration into full brain imaging
systems, are some of the main challenges which need to be
overcome in the coming years.
VI. PANEL DISCUSSIONS: PERSPECTIVES
ON NEURAL SENSING
As part of the workshop, a panel of neural sensors
researchers discussed some of the challenges facing neural
interface technology, and proposed suggestions for how they
could be addressed. Some of the main themes that emerged
from that discussion included: 1) A proposal that flagship
research in neural interfaces should be focused on one or
more clinical or commercial needs that involves a significant
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population of beneficiaries 2) Developing application spaces
should draw on clearly articulated basic science questions
3) New sensing techniques are needed that change the risk
profile associated with neural sensing and 4) The need for
translation-based teams to involve people from many different
disciplines, including some not traditionally associated with
conventional neural interface research.
A. Flagship Applications to Benefit Neural Interface
Development
A common theme of the panel’s deliberations was the idea
that to best advance brain sensor technology, the community
should nucleate around high-priority applications rather than
focus on arbitrary technical or scientific metrics. Instead,
the technical metrics would be driven by the needs of the target
application. With this approach it may be easier to clearly
articulate a focused set of engineering design constraints
and next step research goals that could be used to advance
sensor technology, provide a more direct path to clinical
translation, and help motivate research support. The panel felt
that selecting flagship application(s) should involve identifying
a space in which neural interfaces provided a potential means
to benefit a larger number of people relative to smaller niche
clinical domains. The panel did not feel that identifying
one or more specific application spaces would significantly
impede neural interface research, as the overlapping needs of
many goal applications meant that advancing neural sensor
technology for a given goal application would still benefit
neural technology at large.
The panel also expressed that many neural sensing technol-
ogy questions that involved identifying necessary performance
metrics and pressing technical challenges were difficult to
answer except in the context of specific applications (e.g.
desired electrode stiffness, and whether it may be better to
maintain that stiffness chronically or transiently). For example,
the panel noted that designing systems capable of monitoring
single neurons may be necessary to enable brain-computer
interface (BCI) control of dexterous prosthetics hands or for
basic neuroscience studies, but local field potential (LFP)
activity may be sufficient for other BCI applications (e.g.
computer cursor control), and thus it was difficult to prioritize
a goal sensor resolution for neural interface research as a
whole. However, the panel noted that in the case of BCI,
the clinical population of severely paralyzed individuals who
would potentially benefit from either approach would be
relatively small compared to the clinical need in spaces such as
pain management, with opiate addiction becoming a national
crisis [126], [127], and Deep Brain Stimulation (DBS), which
is currently being used by more than 40,000 people world-
wide [128]. The panel felt that selecting a domain such as DBS
or electroceutical pain management as a high priority neural
interface application space would help the research community
identify a reduced set of clearly articulated, high-priority
technological and scientific goals. The panel expressed many
advantages of focusing on applications: 1) accelerating neural
interface research while also helping to motivate research
investment, 2) providing a flagship platform to explore
regulatory restrictions and health reimbursement obstacles to
neural interface clinical translation, which would benefit from
a larger potential pool of beneficiaries), 3) helping avoid
instances of technological hype outstripping its capabilities
since concrete application goals would provide clear metrics
against which progress could be measured, 4), providing a
means for other neural interface areas, such as BCI, to advance
given that shared domain challenges (e.g. development of less
invasive recording and stimulating techniques).
B. The Need for Basic Science to Support Neural
Sensor Development
While the panel advocated identifying one or more high-
priority application spaces, it also emphasized the need to
improve our basic scientific understanding of the relevant
neural mechanisms associated with: 1) the proposed applica-
tion, 2) the factors affecting device performance, and 3) the
information content of the recorded data. The panel expressed
the opinion that when considering potential high priority
application domains, the degree to which the fundamental
problems associated with the application having been histori-
cally well studied and well understood should be a significant
selection criterion. Similarly, research efforts going forward
would benefit by being able to frame their basic science
questions in regards to the identified application(s) in order
to more clearly articulate their goals. For example, when
asked to assess the importance of novel sensing methods
ability to monitor individual neurons, the panel pointed out
that basic research would be necessary to determine whether
single neuron recording fidelity was important for a given
application. More specifically, research would be necessary to
better quantify the information content of LFP data relative
to single neuron recordings, the temporal stability of LFP
information, the stability by which single neurons can be
tracked over time for a given method, how well information
content scaled with additional sensors for single neuron vs
LFP sources, etc., Only with such basic work would it be
possible to assess the need for single neuron monitoring for
a proposed application. Similarly, when discussing the major
impediments to current clinical translation efforts, the panel
articulated a number of areas for which basic research would
be necessary to overcome translation hurdles, including: safety
studies regarding optogenetic techniques, establishing the con-
sistency with which specific neurons could be linked to sensor
recordings, studies regarding which neural regions should be
targeted for a given application, and investigations into the
long and short term impacts of parameters such as electrode
stiffness on tissue damage and neural monitoring.
C. Reducing the Risk Profiles of Neural Sensors and
Stimulators Would Expand the Space of New Applications
As part of the its deliberations, the panel returned several
times to the idea that a major goal for both neural sensing
and stimulation technologies should be to reduce risk pro-
files associated with deploying and using the technologies.
New application spaces, whether commercial or clinical, must
consider the risk as well as the benefit to the user, which
implies that reducing risk significantly expands the space of
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possible applications that could be used as high-priority focus
areas to support neural interface research. For example, basic
research evaluating the impact of electrode motion, both over
short and long timescales, may show that flexible electrodes
significantly reduce the risk profile for implanted electrodes.
Similarly, when challenged to identify the major impediments
to translating neural interface technology to clinical practice,
the panel highlighted that surgical implantation of a device
significantly complicated clinical translation opportunities, and
even more so impacted potential commercial applications.
With regard to the latter, the panel believed that pursuing
noninvasive technologies for neural recording and stimula-
tion would facilitate identification of a high-priority, large
population application spaces. The panel pointed out there
was significant public interest in neural interfaces, extending
even to growing DIY (“do it yourself”) communities that are
emerging around neural recording technologies (e.g. the Open-
BCI project [129], open source EEG [130] and DIY brain
stimulation methodologies [131]–[134]. The panel argued that
providing a larger number of reliable and effective noninvasive
neural sensing technologies would increase commercial and
public interest and thus increase the probability of a success-
ful high-profile commercial application. These developments
would in-turn provide greater research opportunities for both
invasive and noninvasive neural sensing technologies.
D. Implementing New Neural Interfaces Requires
Integration of Diverse Skill Sets
The panel also advocated that research efforts should draw
on a wide range of knowledge bases and skill sets to effectively
move neural interface technology forward. The panel explicitly
noted that bridging the gap between biology and engineers
was a key hurdle in developing effective new neural sensing
technologies, thus encouraging the formation of multidisci-
plinary teams. The panel emphasized the need for varied
expertise to develop new technologies that can successfully
translate into a clinical setting. For example, not only would
teams need to be able to effectively integrate clinicians, but
they would also need individuals skilled in communication
and commercial applications, such as people with venture
capital expertise. The panel believed that such skill sets are
often overlooked to the detriment of translation efforts. For
example, effectively obtaining venture capital investment often
includes extensive communication skills and being able to
not only clearly describe technical achievements, but also
being able to clearly communicate future requirements while
delineating scientific and engineering risks. Similarly, cur-
rently there is often a cultural clinical aversion against using
neural stimulation-based approaches for clinical applications,
and good communication skills (often themselves a challenge
for research scientists and engineers) will be important to help
open up new application spaces. The panel also noted that
good communication and leadership skills were necessary (but
unfortunately often lacking) for coordinating efforts within
a given team. Some of the panelists pointed to personal
experiences in which they believed that the necessary types
of expertise to support individual components of a project,
such as clinical testing and different types of engineering sills,
had been present in a team, but the main difficulties had
been in bringing the components together effectively. Thus,
they advocated for teams to draw on members with expertise
(to some degree) that crosses different discipline boundaries
to help facilitate team communication and integration of a
project’s different scientific and engineering components.
E. Grand Challenges: Coordination, Barriers
to Entry, and Details
The workshop concluded with a discussion among breakout
groups to identify the grand challenges for Brain sensing.
From these discussions a consensus emerged that there are
no clear grand challenges for a technology because there
is not a singular goal for neural sensing research. Rather,
the group reported that the biggest challenges related to
the coordinating the many different engineering pieces that
must work together for a functional neural technology and
creating robust technologies that can be easily distributed.
The groups reported that there is currently a huge barrier to
entry for neurotechnology developers if they need to create
the end-to-end solution. A move toward modular components
in neurotech would allow engineers to focus on developing
one element of a system that would could integrate into
existing systems. The groups suggested that neurotechnology
development platforms similar to what has been done in
the software industry could also a empower crowd sourced
solutions and communities of DIY’ers to contribute to the
neurotech movement. Finally, the groups argued that the
largest engineering challenge is not unified, but rather a
collection of specific technology challenges ranging from
device performance, packaging, biocompatibility, robust
operation, connectors, wireless power and data, etc. that
together must be solved for “surgeon-proof” technologies.
Despite these challenges the panels remained optimistic that
these are solvable problems over the next decade.
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